Asiatic Acid Salt Extraction for High Purity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The extraction and purification of asiatic acid and asiaticoside from Centella asiatica are hindered by low yields and poor purity, limiting their therapeutic potential for fibrotic and inflammatory diseases, and there is a lack of knowledge on producing asiatic acid salts for therapeutic compositions.
Innovation Solution
A high-purity asiatic acid salt, specifically potassium or trometamol salts, is produced and formulated into a solid dosage form for therapeutic compositions, which can be used to treat fibrotic and inflammatory diseases by administering them to subjects at risk or suffering from conditions like radiation-induced pneumonitis, idiopathic pulmonary fibrosis, and arthritis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If asiatic acid is extracted from Centella asiatica using conventional methods, then the compound can be obtained for therapeutic use, but the yield is low and purity is poor
Solution Approach 1:
The patent applies extraction principles by isolating asiatic acid from Centella asiatica plant material through systematic separation processes. The method selectively extracts the desired compound while removing impurities, achieving both high yield and high purity simultaneously through multiple extraction and purification stages
Solution Approach 2:
The patent utilizes parameter changes in the extraction process, including variations in solvent composition, temperature, pH, and extraction time, to optimize both the quantity of asiatic acid extracted and its purity. By adjusting these parameters systematically, the process achieves superior extraction efficiency and product quality
2Ease of manufacture
If conventional extraction methods are used for asiatic acid, then the process is simple, but the therapeutic potential is limited due to low yield and purity
Solution Approach 1:
The patent divides the extraction and purification process into distinct sequential stages, each optimized for specific objectives. This segmentation allows the process to maintain relative simplicity while achieving high reliability, as each stage builds upon the previous one to progressively improve yield and purity
Solution Approach 2:
The patent implements a continuous extraction and purification process where material flows through multiple treatment stages without interruption. This continuity maintains operational simplicity while ensuring consistent high-quality output, thereby improving therapeutic reliability without significantly complicating the manufacturing process
3Manufacturing precision
If high purity asiatic acid salts are produced, then therapeutic outcomes are improved, but the manufacturing process becomes more complex
Solution Approach 1:
The patent introduces intermediate purification and salt formation steps that act as mediators between the crude extract and the final high-purity salt product. These intermediary stages systematically remove impurities and facilitate controlled salt formation, achieving high purity without requiring overly complex manufacturing systems
Solution Approach 2:
The patent employs controlled parameter changes during salt formation, including pH adjustment, temperature control, and solvent selection, to precipitate high-purity asiatic acid salts. By optimizing these parameters, the process achieves superior product purity through relatively simple procedural modifications rather than complex equipment
Data Source
Figure 1
Figure 2
Figure 3
AI summary
A highly pure asiaticoside and a pharmaceutical grade asiatic acid can be prepared, along with salts of asiatic acid, for use in formulating therapeutic compositions that are suitable for treating arthritis, psoriasis and other inflammatory diseases, as well as pulmonary fibrosis, diabetic nephropathy, and other fibrotic diseases.